Novartis Ag (NVSEF) Net Income towards Common Stockholders (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) Net Income towards Common Stockholders (QoQ) (2009 - 2023) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -24.00%
Sep 30, 2023 443.48%
Jun 30, 2023 -68.06%
Mar 31, 2023 -4.64%
Dec 31, 2022 -38.37%
Sep 30, 2022 -88.00%
Jun 30, 2022 243.19%
Mar 31, 2022 -90.01%
Dec 31, 2021 827.73%
Sep 30, 2021 -81.69%
Jun 30, 2021 582.10%
Mar 31, 2021 -89.53%
Dec 31, 2020 712.75%
Sep 30, 2020 -73.60%
Jun 30, 2020 1,079.38%
Jun 30, 2019 4,744.55%
Mar 31, 2019 -288.46%
Dec 31, 2018 89.92%
Sep 30, 2018 -745.00%
Jun 30, 2018 -31.03%